<?xml version="1.0" encoding="UTF-8"?>
<p id="Par61">Exclusion criteria include a history of hypersensitivity to any cannabinoid, unstable untreated cardiovascular disease, severe hepatic impairment (total bilirubin ≥ 1.5 times the upper limit of the normal range), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≥ 3.0 times the upper limit of the normal range (subjects with liver metastasis may have an AST and ALT of ≥ 5.0 times the upper limit of normal), severe renal impairment (eGFR ≤ 20 mL/min/1.73 m
 <sup>2</sup>), a history of psychiatric disorders (severe depression or anxiety, personality disorder, psychosis, schizophrenia, first-degree relative with schizophrenia and/or suicidal ideation), cognitive impairment (St Louis University Mental Status examination (SLUMS) ≤ 20/30) [
 <xref ref-type="bibr" rid="CR16">16</xref>] and a known substance use disorder (Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) examination scoring &gt; 27) for any substance.
</p>
